HK1036417A1 - A non-stustained release, non-chewable pharmaceutical tablet composition - Google Patents
A non-stustained release, non-chewable pharmaceutical tablet compositionInfo
- Publication number
- HK1036417A1 HK1036417A1 HK01107510A HK01107510A HK1036417A1 HK 1036417 A1 HK1036417 A1 HK 1036417A1 HK 01107510 A HK01107510 A HK 01107510A HK 01107510 A HK01107510 A HK 01107510A HK 1036417 A1 HK1036417 A1 HK 1036417A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- stustained
- release
- tablet composition
- pharmaceutical tablet
- chewable pharmaceutical
- Prior art date
Links
- 239000007916 tablet composition Substances 0.000 title abstract 2
- 239000011230 binding agent Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000001376 precipitating effect Effects 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8896098P | 1998-06-11 | 1998-06-11 | |
PCT/US1999/011798 WO1999063970A1 (en) | 1998-06-11 | 1999-06-07 | Delavirdine tablet formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1036417A1 true HK1036417A1 (en) | 2002-01-04 |
Family
ID=22214517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01107510A HK1036417A1 (en) | 1998-06-11 | 2001-10-29 | A non-stustained release, non-chewable pharmaceutical tablet composition |
Country Status (21)
Country | Link |
---|---|
US (3) | US6177101B1 (xx) |
EP (1) | EP1083885B1 (xx) |
JP (1) | JP4827296B2 (xx) |
KR (2) | KR20070040426A (xx) |
CN (1) | CN1237958C (xx) |
AT (1) | ATE349203T1 (xx) |
AU (1) | AU753241C (xx) |
BR (1) | BR9910481A (xx) |
CA (1) | CA2328703C (xx) |
CY (1) | CY1105924T1 (xx) |
DE (1) | DE69934582T2 (xx) |
DK (1) | DK1083885T3 (xx) |
EA (1) | EA004311B1 (xx) |
ES (1) | ES2277682T3 (xx) |
HK (1) | HK1036417A1 (xx) |
HU (1) | HUP0102206A3 (xx) |
NZ (1) | NZ508762A (xx) |
PL (1) | PL200163B1 (xx) |
PT (1) | PT1083885E (xx) |
WO (1) | WO1999063970A1 (xx) |
ZA (1) | ZA200006090B (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070040426A (ko) * | 1998-06-11 | 2007-04-16 | 파마시아 앤드 업존 캄파니 엘엘씨 | 빠르게 침전하는 약물의 정제 제제 |
MXPA02006324A (es) | 1999-12-23 | 2002-12-13 | Pfizer Prod Inc | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco. |
US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
US20040243118A1 (en) * | 2001-06-01 | 2004-12-02 | Ayers Gregory M. | Device and method for positioning a catheter tip for creating a cryogenic lesion |
US20030073826A1 (en) * | 2001-08-28 | 2003-04-17 | Chao Robert S. | Crystaline clindamycin free base |
DE10164510A1 (de) * | 2001-12-20 | 2003-07-10 | Schering Ag | Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes |
JP2004107258A (ja) * | 2002-09-18 | 2004-04-08 | Ss Pharmaceut Co Ltd | 催眠用圧縮成型製剤 |
US20050163839A1 (en) * | 2003-01-29 | 2005-07-28 | Sun Pharmaceutical Industries Limited | Oral controlled release pharmaceutical composition containing metaxalone as active agent |
JP2006522099A (ja) * | 2003-04-04 | 2006-09-28 | ファルマシア コーポレーション | 複合粒状体からなる経口徐放性圧縮錠 |
WO2004110461A1 (en) | 2003-06-13 | 2004-12-23 | Idh Holding Aps | Treatment of symptoms associated with bacterial vaginosis |
BRPI0412190A (pt) * | 2003-07-01 | 2006-08-22 | Pharmacia & Upjohn Co Llc | sólidos com camada de difusão modulada |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
US20050283146A1 (en) * | 2004-06-17 | 2005-12-22 | Lentz David J | Thermally extended spiral cryotip for a cryoablation catheter |
US20060099253A1 (en) * | 2004-10-20 | 2006-05-11 | Wyeth | Antibiotic product formulation |
US20070059359A1 (en) * | 2005-06-07 | 2007-03-15 | Thomas Backensfeld | Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
WO2008012991A1 (fr) | 2006-07-27 | 2008-01-31 | Kabushiki Kaisha Kobe Seiko Sho | Dispositif de connexion et installation de malaxage possédant un dispositif de malaxage et un dispositif d'entraînement connectés l'un à l'autre par le dispositif de connexion |
CA2617688C (en) * | 2007-02-22 | 2015-08-18 | Alpex Pharma S.A. | Solid dosage formulations containing weight-loss drugs |
US8696606B2 (en) * | 2009-09-28 | 2014-04-15 | Continuous MotionFlow, LLC | Passive motion machine with integrated mechanical DVT prophylactic therapy |
ES2569925T3 (es) | 2009-09-30 | 2016-05-13 | Acura Pharmaceuticals, Inc. | Métodos y composiciones de disuasión del abuso |
JP5226732B2 (ja) * | 2010-05-20 | 2013-07-03 | エスエス製薬株式会社 | 催眠用圧縮成型製剤 |
US20120010216A1 (en) * | 2010-07-06 | 2012-01-12 | Brown Arthur M | Pharmaceutical compositions containing vanoxerine |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
EA032913B1 (ru) | 2012-10-18 | 2019-08-30 | Эббви Инк. | Препараты производных пиримидиндиона |
RU2673818C2 (ru) | 2012-11-30 | 2018-11-30 | Экьюра Фармасьютикалз, Инк. | Саморегулируемое высвобождение фармацевтического ингредиента |
SG11201509998WA (en) | 2013-06-13 | 2016-01-28 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
WO2019218958A1 (zh) * | 2018-05-15 | 2019-11-21 | 江苏豪森药业集团有限公司 | 包含小分子egfr抑制剂的药物组合物及其制备方法 |
CN108619104A (zh) * | 2018-06-29 | 2018-10-09 | 哈尔滨珍宝制药有限公司 | 一种基于盐酸克林霉素的药物组合物及其制备方法 |
CZ309820B6 (cs) * | 2021-04-23 | 2023-11-08 | Pro.Med.Cs Praha A.S. | Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4013785A (en) * | 1975-03-21 | 1977-03-22 | Bristol-Myers Company | Apap tablet containing fumed silica and process for manufacturing same |
ZA855250B (en) * | 1984-08-17 | 1986-02-26 | Upjohn Co | Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing |
GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
DE3708916A1 (de) | 1987-03-19 | 1988-09-29 | Boehringer Ingelheim Kg | Verfahren zur reinigung resorbierbarer polyester |
US5211958A (en) * | 1987-11-30 | 1993-05-18 | Gist-Brocades, N.V. | Pharmaceutical composition and process for its preparation |
DE3868245D1 (de) * | 1987-11-30 | 1992-03-12 | Gist Brocades Nv | Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung. |
US5256699A (en) * | 1988-10-18 | 1993-10-26 | Ciba-Geify Corporation | Dispersible tablet formulation of diclofenac acid free base |
GB8824392D0 (en) * | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
CA2007764C (en) * | 1989-02-24 | 1999-11-30 | Joseph Michael Beaurline | Salsalate tablet |
GB8909793D0 (en) * | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
NZ236393A (en) | 1989-12-13 | 1992-05-26 | Lilly Co Eli | N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions |
US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
US5663169A (en) * | 1992-08-07 | 1997-09-02 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
US5358941A (en) | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
FR2711524B1 (fr) * | 1993-10-21 | 1995-11-24 | Rhone Dpc Europ | Procédé de préparation de compositions orales contenant des quinolones. |
PL180776B1 (pl) | 1994-04-15 | 2001-04-30 | Upjohn Co | Sole monometanosulfoniany 1-[5-metanosulfonamidoindolilo-2-karbonylo]-4-[3-(1-metyloetyloamino)-2-pirydynylo] piperazyny |
US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
US5837292A (en) | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
US5955107A (en) * | 1997-12-12 | 1999-09-21 | Fmc Corporation | Pharmaceutical suspension tablet compositions |
UA72207C2 (uk) * | 1998-04-07 | 2005-02-15 | Брістол- Майєрс Сквібб Фарма Компані | Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення |
KR20070040426A (ko) * | 1998-06-11 | 2007-04-16 | 파마시아 앤드 업존 캄파니 엘엘씨 | 빠르게 침전하는 약물의 정제 제제 |
-
1999
- 1999-06-07 KR KR1020077007572A patent/KR20070040426A/ko not_active Application Discontinuation
- 1999-06-07 AT AT99925951T patent/ATE349203T1/de active
- 1999-06-07 BR BR9910481-4A patent/BR9910481A/pt not_active Application Discontinuation
- 1999-06-07 ES ES99925951T patent/ES2277682T3/es not_active Expired - Lifetime
- 1999-06-07 PT PT99925951T patent/PT1083885E/pt unknown
- 1999-06-07 CN CNB998062316A patent/CN1237958C/zh not_active Expired - Lifetime
- 1999-06-07 KR KR1020007013985A patent/KR100724016B1/ko not_active IP Right Cessation
- 1999-06-07 DK DK99925951T patent/DK1083885T3/da active
- 1999-06-07 US US09/327,135 patent/US6177101B1/en not_active Expired - Lifetime
- 1999-06-07 JP JP2000553039A patent/JP4827296B2/ja not_active Expired - Lifetime
- 1999-06-07 DE DE69934582T patent/DE69934582T2/de not_active Revoked
- 1999-06-07 EA EA200100024A patent/EA004311B1/ru not_active IP Right Cessation
- 1999-06-07 AU AU42134/99A patent/AU753241C/en not_active Expired
- 1999-06-07 HU HU0102206A patent/HUP0102206A3/hu unknown
- 1999-06-07 NZ NZ508762A patent/NZ508762A/en not_active IP Right Cessation
- 1999-06-07 PL PL344328A patent/PL200163B1/pl unknown
- 1999-06-07 CA CA002328703A patent/CA2328703C/en not_active Expired - Lifetime
- 1999-06-07 WO PCT/US1999/011798 patent/WO1999063970A1/en not_active Application Discontinuation
- 1999-06-07 EP EP99925951A patent/EP1083885B1/en not_active Revoked
-
2000
- 2000-09-06 US US09/656,364 patent/US7108864B1/en not_active Expired - Lifetime
- 2000-10-27 ZA ZA200006090A patent/ZA200006090B/xx unknown
-
2001
- 2001-10-29 HK HK01107510A patent/HK1036417A1/xx not_active IP Right Cessation
-
2006
- 2006-07-14 US US11/487,554 patent/US20060257476A1/en not_active Abandoned
-
2007
- 2007-01-15 CY CY20071100050T patent/CY1105924T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR9910481A (pt) | 2001-01-09 |
KR20070040426A (ko) | 2007-04-16 |
NZ508762A (en) | 2003-07-25 |
KR20010052717A (ko) | 2001-06-25 |
DK1083885T3 (da) | 2007-02-26 |
CY1105924T1 (el) | 2011-04-06 |
ZA200006090B (en) | 2001-10-29 |
JP4827296B2 (ja) | 2011-11-30 |
ES2277682T3 (es) | 2007-07-16 |
EP1083885A1 (en) | 2001-03-21 |
CN1237958C (zh) | 2006-01-25 |
DE69934582T2 (de) | 2007-10-04 |
CA2328703C (en) | 2007-10-30 |
AU4213499A (en) | 1999-12-30 |
US20060257476A1 (en) | 2006-11-16 |
ATE349203T1 (de) | 2007-01-15 |
EP1083885B1 (en) | 2006-12-27 |
PT1083885E (pt) | 2007-01-31 |
JP2002517430A (ja) | 2002-06-18 |
US6177101B1 (en) | 2001-01-23 |
US7108864B1 (en) | 2006-09-19 |
DE69934582D1 (de) | 2007-02-08 |
AU753241C (en) | 2003-05-08 |
HUP0102206A2 (hu) | 2002-03-28 |
PL200163B1 (pl) | 2008-12-31 |
CN1301149A (zh) | 2001-06-27 |
WO1999063970A1 (en) | 1999-12-16 |
PL344328A1 (en) | 2001-10-22 |
AU753241B2 (en) | 2002-10-10 |
EA200100024A1 (ru) | 2001-06-25 |
CA2328703A1 (en) | 1999-12-16 |
EA004311B1 (ru) | 2004-02-26 |
HUP0102206A3 (en) | 2002-12-28 |
KR100724016B1 (ko) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036417A1 (en) | A non-stustained release, non-chewable pharmaceutical tablet composition | |
AU3080895A (en) | Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them | |
ZA979220B (en) | New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions. | |
HUP0003058A3 (en) | Soya extract, process for its preparation and pharmaceutical composition | |
AU1729397A (en) | Process to prepare soluble delivery systems using volatile salts | |
HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
HUP9904046A3 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing the same | |
AU7196096A (en) | Long-lasting release Nifedipine preparation | |
HUP0100568A3 (en) | 11beta-halogen-7alpha-substituted estratrienes, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
EP0904781A3 (en) | Improved pharmaceutical composition comprising fenofibrate | |
ZA965294B (en) | Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them. | |
GR3031568T3 (en) | Cyclosporin containing composition and process for the preparation thereof | |
DE69632194D1 (de) | Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
HUP0001093A3 (en) | Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation | |
HUP0004588A3 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them | |
ZA971746B (en) | Taxoids, their preparation and pharmaceutical compositions containing them. | |
HK1024695A1 (en) | Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them | |
HUP9702480A3 (en) | New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same | |
AU5139596A (en) | Pharmaceutical matrix pellets, tablets and composition for the preparation thereof | |
HU9700989D0 (en) | Ortho-substituted benzoyl-guanidines, process for producing them, their use as medicament and diagnosticment, pharmaceutical compositions containing them | |
HU9603388D0 (en) | New taxoids, preparation thereof and pharmaceutical compositions containing them | |
HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20190606 |